Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All drugs

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug	Trials
Pembrolizumab	452
Sodium Chloride	414
Carboplatin	340
Cisplatin	282
Paclitaxel	251
Fluorouracil	232
Oxaliplatin	223
Nivolumab	211
Dexamethasone	205
Rituximab	195
Cyclophosphamide	188
Durvalumab	163
Bevacizumab	162
Capecitabine	157
Paracetamol	156
Atezolizumab	147
Docetaxel	128
Prednisone	127
Tocilizumab	125
Prednisolone	122
Gemcitabine	117
Mycophenolate Mofetil	116
Venetoclax	116
Etoposide	115
Pemetrexed	114
Doxorubicin Hydrochloride	110
Infliximab	99
Lenalidomide	98
Semaglutide	92
Ipilimumab	90
Folinic Acid	89
Acetylsalicylic Acid	89
Placebo	85
Paclitaxel Albumin-Bound	84
Cytarabine	79
Daratumumab	79
Methotrexate	78
Calcium Folinate	78
Fludarabine Phosphate	77
Dapagliflozin	73
Bortezomib	72
Letrozole	72
Olaparib	70
Gemcitabine Hydrochloride	69
Obinutuzumab	68
Azacitidine	66
Trastuzumab	65
Lenvatinib	65
Cetuximab	64
Tacrolimus	63
Fulvestrant	63
Irinotecan	61
Methylprednisolone	60
Irinotecan Hydrochloride Trihydrate	59
Temozolomide	59
Cemiplimab	57
Vincristine Sulfate	57
Trastuzumab Deruxtecan	54
Apixaban	52
Enzalutamide	51
Betamethasone Sodium Phosphate	50
Lidocaine Hydrochloride Monohydrate	50
Amoxicillin	49
Dexamethasone Sodium Phosphate	49
Codeine Phosphate	49
Buclizine Hydrochloride	47
Lidocaine Hydrochloride	47
Exemestane	46
Hydrocortisone	46
Empagliflozin	46
Potassium Chloride	45
Ribociclib	45
Anastrozole	45
Adalimumab	45
Pomalidomide	43
Pertuzumab	43
Doxorubicin	43
Clavulanic Acid	42
Tenofovir Alafenamide	42
Oxygen	42
Clopidogrel	42
Ruxolitinib	41
Rivaroxaban	41
Ibrutinib	41
Ropivacaine Hydrochloride	40
Abemaciclib	40
Trimethoprim	40
Bendamustine Hydrochloride	40
Atorvastatin	40
Metformin Hydrochloride	40
Sulfamethoxazole	40
Carfilzomib	39
Propofol	39
Cyclophosphamide Monohydrate	39
Vinorelbine	38
Emtricitabine	38
Palbociclib	38
Linezolid	38
Ifosfamide	38
Pemetrexed Disodium	38

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 VMX-C001

Clinical trials are studying VMX-C001 in people who take a Factor Xa direct oral anticoagulant and need urgent surgery or another high-bleeding-risk procedure.

2 months ago

#2 LIPASE

Clinical trials are investigating LIPASE, including a new lipase product compared with pancrelipase.

2 months ago

#3 TRIACYLGLYCEROL LIPASE

Clinical trials of TRIACYLGLYCEROL LIPASE are studying a new lipase treatment in adults with exocrine pancreatic insufficiency.

2 months ago

#4 IMA401

Clinical trials are investigating IMA401 in patients with recurrent and/or refractory solid tumors.

2 months ago

#5 ALLERGEN EXTRACTS

Clinical trials are studying BLOMIA TROPICALIS POLYMERIZED EXTRACT as part of a vaccine for dust mite and Blomia tropicalis allergy.

2 months ago

#6 AUR200

Clinical trials are investigating AUR200 in people with generalized myasthenia gravis.

2 months ago

Drugs starting by d

1
Df1001

Diseases, Neoplasms

DF1001 is an innovative immunotherapy drug currently being studied in clinical trials for patients with advanced solid tumors. This article provides an overview of the ongoing research, focusing on the drug’s potential to target natural killer (NK) cells and T-cell activation signals in various types of cancer, including lung, breast, and gastric cancers. The trials aim to assess the safety, effectiveness, and optimal dosing of DF1001, both as a standalone treatment and in combination with other cancer therapies.

Related diseases and areas:
- Neoplasm
1
Df6002

Diseases, Neoplasms

A groundbreaking clinical trial is underway to investigate the potential of DF6002, a new drug being studied for the treatment of advanced solid tumors. This trial aims to evaluate the safety, effectiveness, and biological impact of DF6002 when used alone or in combination with Nivolumab, a known cancer immunotherapy drug. The study focuses on patients with locally advanced or metastatic solid tumors, offering hope for those with limited treatment options.

Related diseases and areas:
- Neoplasm
2
Dfv890

Cardiovascular Diseases, Diseases, Musculoskeletal Diseases

DFV890 is an investigational drug being studied in clinical trials for its potential to treat a variety of medical conditions. These trials aim to evaluate the safety, efficacy, and tolerability of DFV890 in patients with different diseases, including familial cold auto-inflammatory syndrome (FCAS), myeloid diseases, knee osteoarthritis, coronary heart disease, and COVID-19 pneumonia. The studies explore various dosing regimens and compare DFV890 to placebo or standard of care treatments.

Related diseases and areas:
- Osteoarthritis
- Arteriosclerosis
1
Diacerein

Diseases, Skin and Connective Tissue Diseases

Diacerein is a medication that has been the subject of several clinical trials, investigating its effectiveness in treating various medical conditions. These trials have primarily focused on its use in osteoarthritis, particularly of the knee and hip, as well as its potential benefits in other areas such as ocular surface disease and type 2 diabetes. Researchers have been exploring diacerein’s anti-inflammatory properties and its ability to inhibit interleukin-1, a key factor in the progression of certain diseases.

Related diseases and areas:
- Epidermolysis bullosa
5
Diazepam

Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diseases, Disorders of Environmental Origin, Mental Disorders, Nervous System Diseases, Physiological processes, Psychiatry and Psychology

Diazepam, a widely used benzodiazepine medication, is being studied in various clinical trials to explore its potential in treating different medical conditions and to develop new formulations. These trials aim to evaluate the efficacy, safety, and bioavailability of diazepam in different forms and for various purposes, ranging from epilepsy management to alcohol withdrawal treatment.

Related diseases and areas:
2
Diclofenac

Musculoskeletal Diseases, Pathological Conditions, Signs and Symptoms

This article examines various clinical trials investigating the use of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), for pain management in different medical conditions. These studies explore different formulations, dosages, and applications of diclofenac to assess its efficacy, safety, and potential benefits in treating pain across various patient populations.

Related diseases and areas:
- Back pain
4
Diclofenac Diethylamine

Diseases, Hormonal diseases, Immune System Diseases, Musculoskeletal Diseases

This article explores the use of Diclofenac Diethylamine, a topical non-steroidal anti-inflammatory drug (NSAID), in clinical trials. Various studies have investigated its effectiveness and safety for treating conditions like osteoarthritis, ankle sprains, and neck pain. The trials compare different formulations and dosing regimens of Diclofenac Diethylamine gel to assess its impact on pain relief, mobility, and quality of life.

Related diseases and areas:
1
Diclofenac Epolamine

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Therapeutics

This article examines the use of diclofenac epolamine, a nonsteroidal anti-inflammatory drug (NSAID), in various clinical trials. The studies focus on its effectiveness in managing pain from conditions like ankle sprains, soft tissue injuries, and post-surgical discomfort. We’ll explore the drug’s application methods, safety profile, and potential benefits across different patient groups, including children and adults.

Related diseases and areas:
- Osteoarthritis
3
DICLOFENAC POTASSIUM

Diseases, Musculoskeletal Diseases, Nervous System Diseases

Diclofenac potassium is a non-steroidal anti-inflammatory drug (NSAID) that has been extensively studied in clinical trials for its effectiveness in managing various types of pain. This medication works primarily by inhibiting the production of prostaglandins, substances in the body that cause inflammation, pain, and fever. Clinical trials have investigated diclofenac potassium across different formulations (tablets, oral solutions, soft gelatin capsules, and topical gels) and in various clinical scenarios including dental pain, migraines, post-surgical pain, and inflammatory conditions. This article summarizes key findings from recent clinical trials to help patients better understand how diclofenac potassium may be used effectively for pain relief.

Related diseases and areas:
- Migraine
- Back pain
14
Diclofenac Sodium

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Anesthesia and Analgesia, Digestive System Diseases, Diseases, Eye Diseases, Musculoskeletal Diseases, Neoplasms, Otorhinolaryngologic Diseases, Skin and Connective Tissue Diseases, Therapeutics

This article examines several clinical trials investigating the use of diclofenac sodium, a nonsteroidal anti-inflammatory drug (NSAID), in different medical contexts. These studies explore its effectiveness in managing pain, reducing inflammation, and its pharmacokinetic properties when administered through various routes. The trials cover applications ranging from dental pain relief to post-operative care and treatment of skin conditions.

Related diseases and areas:
3
Dicloxacillin

Bacterial Infections and Mycoses, Diseases, Musculoskeletal Diseases

This article examines the use of dicloxacillin, an antibiotic medication, in various clinical trials. These studies investigate dicloxacillin’s effectiveness, potential drug interactions, and its role in treating different infections. The research aims to improve our understanding of how dicloxacillin works in the body and how it can be used most effectively and safely.

Related diseases and areas:
- Staphylococcal bacteraemia
- Osteomyelitis
2
Difelikefalin

Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nervous System Diseases, Skin and Connective Tissue Diseases

Difelikefalin is an investigational drug being studied in clinical trials for its potential to treat moderate to severe itching (pruritus) associated with various conditions. This article summarizes key information from recent clinical trials exploring the use of difelikefalin for chronic itch in patients with kidney disease, atopic dermatitis, and other pruritus-related disorders.

Related diseases and areas:
- Pruritus
- Notalgia paraesthetica
1
Digitoxin

Diseases, Neoplasms

Digitoxin, a cardiac glycoside traditionally used for heart conditions, is now being investigated for its potential benefits in treating cystic fibrosis (CF). This article delves into recent clinical trials that explore the effects of digitoxin on inflammation and lung function in CF patients, offering hope for new treatment options in this challenging genetic disorder.

Related diseases and areas:
- Pancreatic carcinoma
4
Digoxin

Cardiovascular Diseases, Diseases, Neoplasms, Respiratory Tract Diseases

Digoxin, a medication traditionally used for heart conditions, is being investigated in various clinical trials for its potential in treating different diseases. These trials explore digoxin’s effects on heart rhythm disorders, cancer, and liver disease, as well as its interactions with other medications. The research aims to uncover new applications and improve our understanding of this versatile drug.

Related diseases and areas:
1
Digoxin Immune Fab (Ovine)

Cardiovascular Diseases

This article discusses the use of Digoxin Immune Fab (Ovine), also known as DigiFab®, in clinical trials for heart failure treatment. While the primary focus of the trial is on Digoxin, DigiFab® is included as a potential treatment option. The study aims to evaluate the effectiveness and safety of Digoxin in combination with standard care for patients with chronic heart failure, with DigiFab® available as a potential antidote in case of Digoxin toxicity.

Related diseases and areas:
- Cardiac failure chronic
1
Diltiazem

Cardiovascular Diseases, Diseases

Diltiazem, a calcium channel blocker, has been the subject of numerous clinical trials investigating its efficacy in treating various medical conditions. This article explores the use of diltiazem in clinical studies, focusing on its applications in cardiovascular disorders, anal fissures, and drug interactions. We’ll examine how diltiazem is being tested in different formulations and dosages to address specific health concerns and improve patient outcomes.

Related diseases and areas:
- Acute myocardial infarction
1
Diltiazem Hydrochloride

Cardiovascular Diseases, Diseases

Diltiazem Hydrochloride, a calcium channel blocker, has been the subject of numerous clinical trials investigating its effectiveness in treating various medical conditions. This article explores the use of Diltiazem Hydrochloride in clinical studies, focusing on its potential benefits, safety profile, and applications in different areas of medicine.

Related diseases and areas:
- Angina pectoris
1
DIMENHYDRINATE

Diseases, Nervous System Diseases, Nutritional and Metabolic Diseases

Dimenhydrinate, commonly known by brand names such as Dramamine or Gravol, is an antihistamine medication that has been the subject of numerous clinical trials for its effectiveness in treating various conditions. This article explores how dimenhydrinate has been studied in clinical settings, focusing primarily on its use for preventing and treating nausea, vomiting, and vertigo. As an over-the-counter medication that works by affecting the vestibular system and histamine receptors, dimenhydrinate offers potential benefits for patients in diverse medical scenarios, from post-operative recovery to motion sickness and vertigo management.

Related diseases and areas:
- Relapsing-remitting multipl…
12
Dimethyl Fumarate

Diseases, Eye Diseases, Hemic and Lymphatic Diseases, Mental Disorders, Neoplasms, Nervous System Diseases, Psychiatry and Psychology

Dimethyl fumarate, also known as Tecfidera, is a medication that has been the subject of numerous clinical trials, primarily for its use in treating multiple sclerosis (MS). These trials have explored its efficacy, safety, and mechanisms of action in relapsing-remitting MS, as well as its potential applications in other conditions such as acute ischemic stroke. This article summarizes key findings from various clinical trials investigating dimethyl fumarate and its impact on patients with MS and other neurological conditions.

Related diseases and areas:
3
Dimeticone

Digestive System Diseases, Female Urogenital Diseases and Pregnancy Complications, Hormonal diseases, Neoplasms

Dimeticone, also known as dimethicone, is a versatile drug being studied in various clinical trials. These studies focus on its potential to enhance mucosal visibility during endoscopic procedures and its effectiveness in treating scalp psoriasis. Researchers are exploring how dimeticone, alone or in combination with other substances, can improve medical examinations and treatments for patients with different conditions.

Related diseases and areas:
3
Dinoprostone

Diseases, Female Urogenital Diseases and Pregnancy Complications, Reproductive and Urinary Physiological Phenomena

This article examines the use of dinoprostone, a prostaglandin E2 medication, in clinical trials for labor induction and cervical ripening. Dinoprostone is commonly used in various formulations, including vaginal inserts and gels, to prepare the cervix for labor and stimulate contractions in pregnant women at or near term. The trials discussed here compare dinoprostone to other methods and evaluate its efficacy and safety for both inpatient and outpatient use in different clinical scenarios.

Related diseases and areas:
- Foetal growth restriction
- Preterm premature rupture o…
8
Dinutuximab Beta

Diseases, Neoplasms, Nervous System Diseases

Dinutuximab Beta, also known as ch14.18/CHO or Qarziba, is an innovative immunotherapy drug being studied in several clinical trials for the treatment of high-risk neuroblastoma and other cancers. This article explores the ongoing research into Dinutuximab Beta’s efficacy, safety, and potential applications in various cancer types, including neuroblastoma, sarcomas, and leiomyosarcoma.

Related diseases and areas:
10
Diphenhydramine

Hemic and Lymphatic Diseases, Neoplasms, Nervous System Diseases

Diphenhydramine, a widely used antihistamine, has been the subject of several clinical trials to evaluate its effectiveness and safety in treating allergies and related conditions. These studies have focused on various aspects, including its use in different age groups, formulations, and comparisons with other medications. This article summarizes key findings from clinical trials involving diphenhydramine, providing valuable insights for patients and healthcare providers.

Related diseases and areas:
28
Diphenhydramine Hydrochloride

Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Immune System Diseases, Immune system processes, Mental Disorders, Metabolism, Neoplasms, Nervous System Diseases, Skin and Connective Tissue Diseases

This article examines various clinical trials investigating the use of Diphenhydramine Hydrochloride, a common antihistamine medication. These studies explore its effectiveness in treating conditions such as allergies, sleeplessness, and its pharmacokinetic properties in different age groups. The trials also compare Diphenhydramine Hydrochloride with other medications and formulations, providing valuable insights into its efficacy and safety profile.

Related diseases and areas:
2
Diphenhydramine Hydrochloride Bp

Environment and Public Health, Eye Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, Neoplasms

This article examines recent clinical trials investigating the use of Diphenhydramine Hydrochloride BP in cancer treatment, particularly for lymphomas. Diphenhydramine, commonly known as an antihistamine, is being studied as a supportive medication in novel cancer therapies. The trials focus on its potential role in managing side effects and improving patient outcomes when used alongside other cancer treatments.

Related diseases and areas:
2
Diphtheria Toxoid Adsorbed On Aluminium Hydroxide, Hydrated And Aluminium Phosphate

Bacterial Infections and Mycoses, Diseases, Nervous System Diseases

This article discusses clinical trials involving the use of Diphtheria Toxoid Adsorbed On Aluminium Hydroxide, Hydrated And Aluminium Phosphate in combination with other vaccine components. These trials aim to evaluate the safety, efficacy, and immune response of this vaccine formulation, particularly when administered alongside other vaccines like tetanus and pertussis. The studies focus on various aspects, including dosage, administration methods, and potential side effects.

Related diseases and areas:
- Streptococcal infection
- Multiple sclerosis relapse
4
Dipyridamole

Cardiovascular Diseases, Diseases, Nervous System Diseases

This article explores the use of dipyridamole, also known by brand names like Persantine and Permole, in various clinical trials. Dipyridamole is being studied for its potential benefits in conditions such as HIV, cardiovascular diseases, and even schizophrenia. The drug works by increasing adenosine levels in the body, which may have protective effects against ischemia-reperfusion injury and inflammation. Through these trials, researchers aim to better understand dipyridamole’s mechanisms of action and its potential to improve patient outcomes in different medical scenarios.

Related diseases and areas:
- Cerebrovascular accident
- Stress cardiomyopathy
2
Dirocaftor

Diseases, Respiratory Tract Diseases

Dirocaftor is a promising drug being studied in clinical trials for the treatment of cystic fibrosis (CF). These trials aim to assess the efficacy and safety of Dirocaftor when used in combination with other drugs (Posenacaftor and Nesolicaftor) in adults with CF who have rare genetic mutations. The studies are designed to help researchers understand how well this drug combination works in improving lung function and other important aspects of CF management.

Related diseases and areas:
- Cystic fibrosis
5
Diroximel Fumarate

Diseases, Nervous System Diseases

Diroximel fumarate, also known as VUMERITY or BIIB098, is a drug being studied in clinical trials for the treatment of relapsing forms of multiple sclerosis (MS). These trials aim to assess the safety, tolerability, effectiveness, and long-term outcomes of diroximel fumarate in patients with MS. The studies are evaluating various aspects such as persistence on treatment, impact on relapses and disability progression, cognitive effects, and patient-reported outcomes. Additionally, some trials are examining the drug’s use during pregnancy and comparing it to other MS treatments.

Related diseases and areas:
6
Disitamab Vedotin

Diseases, Neoplasms

Disitamab Vedotin, also known as RC48-ADC, is an antibody-drug conjugate being studied in clinical trials for various types of cancer that express HER2 (human epidermal growth factor receptor 2). This article summarizes key information about ongoing clinical trials evaluating Disitamab Vedotin’s safety and efficacy in treating different HER2-positive solid tumors, including breast, gastric, colorectal, and other cancers.

Related diseases and areas:
6
Disodium Folinate

Digestive System Diseases, Diseases, Neoplasms

Disodium folinate, also known as sodium folinate or leucovorin calcium, is being studied in several clinical trials for its potential role in cancer treatment, particularly in combination with other chemotherapy drugs. This article explores the use of disodium folinate in ongoing clinical trials for various types of cancer, including colorectal, esophagogastric, and other advanced cancers.

Related diseases and areas:
1
Disodium Levofolinate

Diseases, Neoplasms

Disodium Levofolinate, also known as Sodium Levofolinate or Levoleucovorin Disodium, is a medication being studied in clinical trials for various types of cancer. This article explores its use in combination with other drugs for treating conditions such as metastatic esophageal cancer, colon cancer, and pancreatic cancer. We’ll examine how researchers are investigating its potential to improve treatment outcomes and patient quality of life.

Related diseases and areas:
- Colorectal cancer stage III
- Colorectal cancer stage II
3
DISODIUM PHOSPHATE

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Disodium phosphate is a compound used in various medical applications, particularly in clinical trials focusing on bowel preparation for procedures like colonoscopy and sigmoidoscopy, as well as in combination therapies for cancer treatment. This article explores how disodium phosphate has been utilized in clinical research, its effectiveness compared to alternative preparations, and its safety profile. Understanding the role of this compound in medical procedures and treatments can help patients make informed decisions about their healthcare options when these preparations are prescribed.

Related diseases and areas:
- Angelman’s syndrome
1
Disulfiram

Diseases, Neoplasms

Disulfiram, commonly known as Antabuse, has been the subject of various clinical trials exploring its potential beyond its traditional use in alcohol addiction treatment. These studies investigate its efficacy in treating cocaine dependence, HIV infection, breast cancer, and even its potential neuroprotective effects in Alzheimer’s disease. This article summarizes key findings from recent clinical trials using disulfiram in different medical conditions.

Related diseases and areas:
- Breast cancer metastatic
4
Divarasib

Diseases, Neoplasms

Divarasib is an investigational drug being studied in several clinical trials for the treatment of advanced cancers, particularly non-small cell lung cancer (NSCLC) and colorectal cancer. These trials aim to evaluate the safety, efficacy, and pharmacokinetics of Divarasib, both as a single agent and in combination with other cancer therapies. The studies focus on patients with specific genetic mutations, such as KRAS G12C, and explore Divarasib’s potential in various treatment settings.

Related diseases and areas:
1
Dl-Alpha Tocopherol Acetate

Diseases, Stomatognathic Diseases

This article discusses a clinical trial investigating the use of Dl-Alpha Tocopherol Acetate, also known as Vitamin E, as part of the PENTO protocol for treating Medication-Related Osteonecrosis of the Jaw (MRONJ). The trial aims to assess the effectiveness of this treatment in patients who have developed jaw bone problems due to certain medications. We’ll explore the trial’s objectives, eligibility criteria, and potential benefits for patients suffering from this condition.

Related diseases and areas:
- Osteonecrosis of jaw
2
Dl-Alpha-Tocopherol

Cardiovascular Diseases, Nutritional and Metabolic Diseases

This article discusses two clinical trials investigating the use of Dl-Alpha-Tocopherol, also known as vitamin E, in treating Alzheimer’s disease and preventing atherosclerosis. These studies aim to evaluate the potential benefits of vitamin E supplementation in slowing disease progression and improving patient outcomes.

Related diseases and areas:
- Cardiogenic shock
- Fatty acid oxidation disorder
1
Dmd06-Mab

Diseases, Musculoskeletal Diseases

A groundbreaking clinical trial is underway to evaluate the safety and efficacy of DMD06-Mab, an innovative cell therapy for non-ambulant patients with Duchenne Muscular Dystrophy (DMD). This phase I/IIa study aims to restore dystrophin production in affected muscles through a single injection of genetically modified autologous mesoangioblasts (MABs). The trial focuses on patients with exon 51 skippable mutations and could potentially offer new hope for those living with this challenging condition.

Related diseases and areas:
- Duchenne muscular dystrophy
1
DNL593

Diseases, Nervous System Diseases

A promising clinical trial is underway to investigate DNL593, a potential treatment for frontotemporal dementia (FTD). This Phase 1/2 study aims to evaluate how safe DNL593 is, how well it’s tolerated, and how it works in the body. The trial involves both healthy participants and those diagnosed with frontotemporal dementia caused by GRN mutations (FTD-GRN). The study is being conducted in multiple stages, starting with single doses in healthy individuals before moving to multiple doses in FTD patients over 25 weeks, with an optional 18-month extension period. This research represents an important step in developing new treatment options for this challenging form of dementia.

Related diseases and areas:
- Frontotemporal dementia
3
Dnth103

Diseases, Immune System Diseases

DNTH103 is an investigational drug currently being studied in clinical trials for the treatment of two neurological conditions: Multifocal Motor Neuropathy (MMN) and Generalized Myasthenia Gravis (gMG). These Phase 2 studies aim to evaluate the safety, tolerability, pharmacometrics, and efficacy of DNTH103 in adult patients. The trials involve randomized, double-blinded, placebo-controlled designs to thoroughly assess the potential benefits and risks of this new treatment option.

Related diseases and areas:
7
Dobutamine

Anesthesia and Analgesia, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diseases

Dobutamine is a medication commonly used in clinical trials to evaluate and treat various cardiac conditions. This article explores recent clinical trials investigating the effects of dobutamine on heart function, blood flow, and patient outcomes across different cardiac disorders. From assessing its impact on patients with heart failure to studying its use in stress echocardiography, these trials aim to better understand how dobutamine can be utilized to improve cardiac care and management.

Related diseases and areas:
13
Dobutamine Hydrochloride

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Anesthesia and Analgesia, Bacterial Infections and Mycoses, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diseases, Neoplasms, Pathological Conditions, Signs and Symptoms, Respiratory Tract Diseases, Therapeutics

This article explores the use of Dobutamine Hydrochloride in various clinical trials. Dobutamine is a medication used to treat heart conditions and improve blood flow. The trials discussed here investigate its effects on different aspects of cardiovascular function, including hepatic blood flow, cardiac conduction, and treatment of sepsis and heart failure. We’ll examine how researchers are studying this drug to better understand its potential benefits and optimal usage in medical settings.

Related diseases and areas:
128
Docetaxel

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Digestive System Diseases, Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Neoplasms, Otorhinolaryngologic Diseases, Respiratory Tract Diseases, Therapeutics

Docetaxel, also known by its brand name Taxotere, is a chemotherapy drug being studied in various clinical trials for the treatment of different types of cancer. These trials aim to evaluate its effectiveness, safety, and potential combinations with other drugs to improve outcomes for patients with advanced solid tumors, breast cancer, and other malignancies.

Related diseases and areas:
1
Doconexent

Nutritional and Metabolic Diseases

This article discusses a clinical trial investigating the use of Doconexent, a component of a fat emulsion, in pediatric patients with Long-chain Fatty Acid Oxidation Disorders (LC-FAOD). The study aims to compare the effects of triheptanoin, which contains Doconexent, with medium-chain triglycerides (MCT) on major clinical events in children with LC-FAOD. This research is crucial for understanding potential treatments for this rare metabolic condition.

Related diseases and areas:
- Fatty acid oxidation disorder
2
Dog Epithelia

Immune System Diseases

This article discusses clinical trials investigating the use of Dog Epithelia in allergy treatments. Dog Epithelia, a common allergen, is being studied as a potential component in immunotherapy for allergic conditions such as rhinitis and rhinoconjunctivitis. These trials aim to assess the efficacy and safety of various formulations containing Dog Epithelia for managing allergic symptoms and improving patients’ quality of life.

Related diseases and areas:
3
Dog Epithelium Extract

Immune System Diseases

This article examines recent clinical trials investigating the use of Dog Epithelium Extract in allergy testing. While the primary focus of these studies is on other allergens like birch, grass, and olive pollen, Dog Epithelium Extract is included as a comparative allergen in skin prick tests. These trials aim to assess the efficacy and safety of various immunotherapy treatments for allergic rhinitis and rhinoconjunctivitis, providing valuable insights into allergy diagnosis and management.

Related diseases and areas:
5
Dolutegravir

Diseases, Immune System Diseases, Musculoskeletal Diseases, Virus Diseases

This article examines the use of dolutegravir, an integrase inhibitor drug, in clinical trials for the treatment of HIV infection. Dolutegravir has shown promise in suppressing HIV replication and maintaining viral suppression in both treatment-naive and treatment-experienced patients. The trials discussed here evaluate dolutegravir’s efficacy, safety, pharmacokinetics, and potential side effects when used alone or in combination with other antiretroviral medications.

Related diseases and areas:
- HIV infection
15
Dolutegravir Sodium

Digestive System Diseases, Diseases, Immune System Diseases, Musculoskeletal and Neural Physiological Phenomena, Nervous System Diseases, Pathological Conditions, Signs and Symptoms, Phenomena and Processes, Virus Diseases

This article examines the use of Dolutegravir Sodium, an antiretroviral medication, in clinical trials for the treatment of HIV. We’ll explore how researchers are investigating its effectiveness, safety profile, and potential benefits compared to other HIV treatments. The trials aim to better understand Dolutegravir’s role in managing HIV infections and improving patient outcomes.

Related diseases and areas:
- HIV infection
- Amyotrophic lateral sclerosis
2
Domperidone

Diseases, Nervous System Diseases, Nutritional and Metabolic Diseases

Domperidone is a medication that has been the subject of several clinical trials investigating its potential benefits in treating various medical conditions. These trials have explored its use in gastroparesis, multiple sclerosis, breast milk production, and other disorders. This article summarizes the key findings from these studies and provides insights into the potential applications of domperidone in clinical practice.

Related diseases and areas:
- Type 1 diabetes mellitus
- Parkinson’s disease
13
Domvanalimab

Digestive System Diseases, Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms

Domvanalimab is an innovative immunotherapy drug currently being investigated in several clinical trials for the treatment of various types of cancer. This article provides an overview of ongoing research into domvanalimab’s potential as a cancer treatment, either alone or in combination with other immunotherapy agents. The trials aim to evaluate its safety, efficacy, and optimal use in different cancer types and stages.

Related diseases and areas:
3
Donanemab

Diseases, Nervous System Diseases

Donanemab, also known as LY3002813, is an investigational drug being studied as a potential treatment for Alzheimer’s disease. This article explores the ongoing clinical trials evaluating donanemab’s safety, efficacy, and impact on brain amyloid plaques in patients with early symptomatic Alzheimer’s disease.

Related diseases and areas:
1
Donepezil

Diseases, Mental Disorders, Nervous System Diseases

This article delves into the use of Donepezil, a widely studied drug for Alzheimer’s disease, in various clinical trials. We’ll examine how different dosages and formulations of Donepezil have been tested to treat severe Alzheimer’s disease, Dementia with Lewy Bodies (DLB), and other related conditions. The trials explore the drug’s efficacy, safety, and pharmacokinetics in diverse patient populations, providing valuable insights into its potential as a treatment option.

Related diseases and areas:
- Dementia Alzheimer’s type
5
Donepezil Hydrochloride

Diseases, Mental Disorders, Nervous System Diseases, Psychiatry and Psychology, Skin and Connective Tissue Diseases

This article examines the use of Donepezil Hydrochloride, also known as Aricept, in clinical trials for various neurological conditions. Donepezil is primarily studied for its effects on cognitive function, particularly in Alzheimer’s disease, dementia with Lewy bodies, and vascular dementia. The trials explore its efficacy, safety, and potential benefits in improving memory, attention, and daily functioning in patients with these conditions.

Related diseases and areas:
3
Donidalorsen

Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diseases, Genetic Phenomena, Phenomena and Processes

Donidalorsen is an innovative drug being studied in clinical trials for the treatment of Hereditary Angioedema (HAE). This article explores the ongoing research, potential benefits, and important information about Donidalorsen in various clinical trial phases. The drug, also known as ISIS 721744 or IONIS-PKK-LRx, is administered subcutaneously and shows promise in reducing HAE attacks and improving the quality of life for patients with this rare genetic condition.

Related diseases and areas:
- Hereditary angioedema
1
Dopamine Hydrochloride

Cardiovascular Diseases

Dopamine Hydrochloride is a medication being studied in several clinical trials for its potential benefits in treating various medical conditions. These trials aim to evaluate its effectiveness and safety in different patient populations, including premature infants, adults undergoing surgery, and individuals with specific health issues. The research focuses on dopamine’s effects on blood pressure, heart function, kidney function, and other physiological processes.

Related diseases and areas:
- Renal impairment
- Heart failure with reduced …
15
Doravirine

Diseases, Immune System Diseases, Virus Diseases

Doravirine is a novel antiretroviral medication being studied in clinical trials for the treatment of HIV infection. These trials aim to evaluate doravirine’s safety, efficacy, and pharmacokinetics in various patient populations, including those with renal or hepatic impairment, pregnant women, and elderly patients. The studies also examine doravirine’s ability to suppress viral replication in genital fluids and its potential use in patients with multiple drug resistance.

Related diseases and areas:
- HIV infection
1
Dordaviprone

Diseases, Neoplasms

Dordaviprone, also known as ONC201, is an innovative drug being studied in various clinical trials for its potential in treating different types of cancer. This article explores the ongoing research on dordaviprone, focusing on its use in gliomas, endometrial cancer, and colorectal cancer prevention. We’ll examine the drug’s mechanism of action, its administration in different trials, and the preliminary findings from these studies.

Related diseases and areas:
- Malignant glioma
- Brain stem glioma
8
Dornase Alfa

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Bacterial Infections and Mycoses, Cardiovascular Diseases, Diagnosis, Diseases, Neoplasms, Nervous System Diseases, Respiratory Tract Diseases, Surgical Procedures, Operative, Therapeutics

Dornase Alfa, also known as Pulmozyme, is a recombinant human DNase enzyme that has been widely used in the treatment of cystic fibrosis. Recent clinical trials are exploring its potential benefits in various other respiratory conditions, including COVID-19, acute respiratory distress syndrome (ARDS), and ventilator-associated infections. This article summarizes the ongoing research and potential applications of Dornase Alfa beyond its traditional use.

Related diseases and areas:
1
Dorocubicel

Diseases, Hemic and Lymphatic Diseases

Dorocubicel, an innovative drug being studied in clinical trials, offers hope for patients with high-risk acute leukemia and myelodysplasia. This article explores the ongoing research on Dorocubicel, which uses expanded cord blood transplantation to potentially improve outcomes for patients requiring allogeneic hematopoietic stem cell transplantation.

Related diseases and areas:
- Acute leukaemia
1
Dorzolamide

Eye Diseases

This article examines the use of dorzolamide, a carbonic anhydrase inhibitor, in various clinical trials for eye disorders. Dorzolamide is commonly used to treat conditions like glaucoma and ocular hypertension by reducing intraocular pressure. The trials discussed here investigate its efficacy and safety, often in combination with other medications, for treating different eye conditions.

Related diseases and areas:
- Retinitis pigmentosa

Explore popular drugs in clinical trials

Starting by letter

Most popular drugs

New drugs in trials

#1 VMX-C001

#2 LIPASE

#3 TRIACYLGLYCEROL LIPASE

#4 IMA401

#5 ALLERGEN EXTRACTS

#6 AUR200

Drugs starting by d

We use cookies